Integrin alpha V beta 6

Integrin alpha V beta 6 Overview

English NameIntegrin alpha-V/beta-6Approved Drugs0
Drugs in Clinical Trials6Target Synonym
Highest Development StagePhase 2 Clinical
English NameIntegrin alpha-V/beta-6
Target Synonym
Approved Drugs0
Drugs in Clinical Trials6
Highest Development StagePhase 2 Clinical

Integrin alpha V beta 6 Background

Integrin alpha V beta 6 is a heterodimer of beta-6 associating with alpha-V. Integrin alpha-V beta-6 is a receptor for fibronectin and cytotactin. It recognizes the sequence R-G-D in its ligands. Internalisation of integrin alpha-V beta-6 via clathrin-mediated endocytosis promotes carcinoma cell invasion. Also, Integrin alpha-V beta-6 acts as a receptor for coxsackievirus A9 and coxsackievirus B1 as well as herpes simplex virus-1/HHV-1. Furthermore, it binds the TGF-beta latency‑associated peptide (LAP) and activates TGF-beta 1 or TGF-beta 3 from large latent complexes. This activation requires interaction with LTBP-1 and fibronectin, and is enhanced by PAR-1.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IDL-2965IDL-2965Phase 2 ClinicalIndalo Therapeutics IncIdiopathic Pulmonary Fibrosis; Metabolic Dysfunction-Associated Steatotic Liver Disease
Details
BexotegrastPLN-74809Phase 2 ClinicalPliant Therapeutics IncCholangitis, Sclerosing; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Respiratory Distress Syndrome, Adult
Details
NesvategrastSF-0166; OTT-166(OcuTerra Therapeutics)Phase 2 ClinicalOcuTerra Therapeutics Inc, Scifluor Life Sciences IncDiabetic macular oedema; Diabetic Retinopathy; Macular Degeneration
Details
18F-αvβ6-Binding-Peptide18F-αvβ6-BPPhase 1 ClinicalNational Cancer Institute, National Institutes Of HealthBreast Neoplasms; Colonic Neoplasms; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Lung Neoplasms; Metastatic breast cancer; Pancreatic Neoplasms; Rectal Neoplasms
Details
[18F]FP-R01-MG[18F]FP-R01-MG-F2; [18F]FP-R01-MGPhase 1 ClinicalChinese Academy Of Medical Science & Peking Union Medical College, Pliant Therapeutics Inc, Stanford UniversityBrain metastases; Carcinoma, Non-Small-Cell Lung; Cholangitis, Sclerosing; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Pancreatic Neoplasms
Details
Ga-68-TrivehexinRAD-301Phase 1 ClinicalTrimt GmbHCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Esophageal Squamous Cell Carcinoma; Ovarian Neoplasms; Pancreatic Neoplasms; Uterine Cervical Neoplasms
Details

Product Reviews

  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland